A 2023 Lancet study reveals 15-20% of type 2 diabetes patients exhibit autoimmune markers, with new ADA guidelines advocating combined GADA/ICA/IAA testing to prevent diagnostic delays and improve out...
Clinical Diagnostics
Hot News
Ziba Guru
your path to beautiful life